National Bank of Canada’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79K | Buy |
5,111
+145
| +3% | +$2.24K | ﹤0.01% | 1529 |
|
|
2025
Q1 | $73.8K | Buy |
4,966
+429
| +9% | +$6.38K | ﹤0.01% | 1472 |
|
|
2024
Q4 | $60.1K | Sell |
4,537
-43
| -0.9% | -$569 | ﹤0.01% | 1535 |
|
|
2024
Q3 | $65.1K | Hold |
4,580
| – | – | ﹤0.01% | 1455 |
|
|
2024
Q2 | $59.2K | Hold |
4,580
| – | – | ﹤0.01% | 1493 |
|
|
2024
Q1 | $60.6K | Hold |
4,580
| – | – | ﹤0.01% | 1506 |
|
|
2023
Q4 | $65.6K | Hold |
4,580
| – | – | ﹤0.01% | 1517 |
|
|
2023
Q3 | $69.3K | Hold |
4,580
| – | – | ﹤0.01% | 1504 |
|
|
2023
Q2 | $71.8K | Hold |
4,580
| – | – | ﹤0.01% | 1521 |
|
|
2023
Q1 | $75.5K | Hold |
4,580
| – | – | ﹤0.01% | 1467 |
|
|
2022
Q4 | $71.4K | Hold |
4,580
| – | – | ﹤0.01% | 1503 |
|
|
2022
Q3 | $59K | Buy |
+4,580
| New | +$59K | ﹤0.01% | 1488 |
|